Up-regulation of long noncoding RNA MBNL1-AS1 suppresses breast cancer progression by modulating miR-423-5p/CREBZF axis

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Okazaki Y, Furuno M, Kasukawa T, et al. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature. 2002;420(6915):563–573.
   PubMed Web of Science ®Google Scholar
• Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013;152(6):1298–1307.
   PubMed Web of Science ®Google Scholar
• Zhu M, Wang Q, Tian P, et al. A long non-coding RNA specifically expressed in early embryos programs the metabolic balance in adult mice. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2021;1867(1):165988.
   PubMed Web of Science ®Google Scholar
• Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21(6):354–361.
   PubMed Web of Science ®Google Scholar
• Choi M, Lu YW, Zhao J, et al. Transcriptional control of a novel long noncoding RNA Mymsl in smooth muscle cells by a single Cis-element and its initial functional characterization in vessels. J Mol Cell Cardiol. 2020;138:147–157.
   PubMed Web of Science ®Google Scholar
• Tang R, Qi Q, Wu R, et al. The polymorphic terminal-loop of pre-miR-1307 binding with MBNL1 contributes to colorectal carcinogenesis via interference with Dicer1 recruitment. Carcinogenesis. 2015;36(8):867–875.
   PubMed Web of Science ®Google Scholar
• Zhu K, Wang Y, Liu L, et al. Long non-coding RNA MBNL1-AS1 regulates proliferation, migration, and invasion of cancer stem cells in colon cancer by interacting with MYL9 via sponging microRNA-412-3p. Clin Res Hepatol Gastroenterol. 2020;44(1):101–114.
   PubMed Web of Science ®Google Scholar
• Wei X, Wang B, Wang Q, et al. MiR-362-5p, which is regulated by long non-coding RNA MBNL1-AS1, promotes the cell proliferation and tumor growth of bladder cancer by targeting QKI. Front Pharmacol. 2020;11(164). DOI:10.3389/fphar.2020.00164
   Google Scholar
• Ye W, Lv Q, Wong CK, et al. The effect of central loops in miRNA:MRE duplexes on the efficiency of miRNA-mediated gene regulation. PLoS One. 2008;3(3):e1719.
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell. 2011;146(3):353–358.
   PubMed Web of Science ®Google Scholar
• Lopez-Mateo I, Villaronga MA, Llanos S, et al. The transcription factor CREBZF is a novel positive regulator of p53. Cell Cycle. 2012;11(20):3887–3895.
   PubMed Web of Science ®Google Scholar
• Wang G, Duan P, Liu F, et al. Long non-coding RNA CASC7 suppresses malignant behaviors of breast cancer by regulating miR-21-5p/FASLG axis. Bioengineered. 2021;12(2):11555–11566.
   PubMed Web of Science ®Google Scholar
• Wang G, Bai X, Jiang G, et al. GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Bioengineered. 2021;12(1):30–43.
   PubMed Web of Science ®Google Scholar
• Tang F, Lu Z, Wang J, et al. Competitive endogenous RNA (ceRNA) regulation network of lncRNAs, miRNAs, and mRNAs in Wilms tumour. BMC Med Genomics. 2019;12(1):194.
   PubMed Web of Science ®Google Scholar
• Hai T, Hartman MG. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene. 2001;273(1):1–11.
   PubMed Web of Science ®Google Scholar
• Xie YB, Lee OH, Nedumaran B, et al. SMILE, a new orphan nuclear receptor SHP-interacting protein, regulates SHP-repressed estrogen receptor transactivation. Biochem J. 2008;416(3):463–473.
   PubMedGoogle Scholar
• Bozulic L, Hemmings BA. PIKKing on PKB: regulation of PKB activity by phosphorylation. Curr Opin Cell Biol. 2009;21(2):256–261.
   PubMed Web of Science ®Google Scholar
• Chen Y, Huang L, Dong Y, et al. Effect of AKT1 (p. E17K) hotspot mutation on malignant tumorigenesis and prognosis. Front Cell Dev Biol. 2020;8:573599.
   PubMed Web of Science ®Google Scholar
• Maass PG, Luft FC, B?hring S. Long non-coding RNA in health and disease. J Mol Med. 2014;92(4):337–346.
   PubMed Web of Science ®Google Scholar
• Xing Z, Lin A, Li C, et al. lncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell. 2014;159(5):1110–1125.
   PubMed Web of Science ®Google Scholar
• Vennin C, Spruyt N, Dahmani F, et al. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget. 2015;6(30):29209–29223.
   PubMedGoogle Scholar
• Gupta RA, Shah N, Wang KC. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071–1076.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Huang H, Huang L, et al. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas. Sci China Life Sci. 2014;57(3):315–326.
   PubMed Web of Science ®Google Scholar
• Cordiali-Fei P, Trento E, Giovanetti M, et al. Analysis of the ORFK1 hypervariable regions reveal distinct HHV-8 clustering in Kaposi’s sarcoma and non-Kaposi’s cases. J Exp Clin Cancer Res. 2015;34(1):1.
   PubMedGoogle Scholar
• Liang W-C, Fu W-M, Wong C-W, et al. The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget. 2015;6(26):22513–22525.
   PubMedGoogle Scholar
• Stiuso P, Potenza N, Lombardi A, et al. MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib. Mol Ther Nucleic Acids. 2015;4:e233.
   PubMedGoogle Scholar
• Liu J, Wang X, Yang X, et al. miRNA423-5p regulates cell proliferation and invasion by targeting trefoil factor 1 in gastric cancer cells. Cancer Lett. 2014;347(1):98–104.
   PubMed Web of Science ®Google Scholar
• Dai T, Zhao X, Li Y, et al. miR-423 promotes breast cancer invasion by activating NF-κB signaling. Onco Targets Ther. 2020;13:5467.
   PubMedGoogle Scholar
• Carnero A, Blanco-Aparicio C, Renner O, et al. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets. 2008;8(3):187–198.
   PubMed Web of Science ®Google Scholar